Clinical significance of serum CA-125, CA19-9 and CEA in pulmonary tuberculosis with and without type 2 diabetes
Tuberculosis (TB) has existed for millennia and remains a major global health problem. In 2015, TB led to approximately 1.4 million deaths [1]. China has the world's third largest TB epidemic, with more than 1.3 million new cases of TB every year [2]. As a consequence of its rapid economic development, aging, changed lifestyles and urbanization, China has also witnessed an escalating epidemic of diabetes mellitus (DM) [3]. DM is a well-known risk factors for the development of pulmonary TB (PTB).
Source: Tuberculosis - Category: Respiratory Medicine Authors: Zhi-xiang Du, Man-man Liang, Jing Sun, Wen-jie Wang, Yin-hua Liu, Jiang-Hua Yang Source Type: research
More News: China Health | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Epidemics | Epidemiology | Respiratory Medicine | Tuberculosis